Secondary Logo

Journal Logo


The Effect of Ankle-Foot Orthoses on Community-Based Walking in Cerebral Palsy

A Clinical Pilot Study

Bjornson, Kristie PT, PhD; Zhou, Chuan PhD; Fatone, Stefania PhD, BPO (Hons); Orendurff, Michael PhD; Stevenson, Richard MD; Rashid, Sariya MS

Author Information
doi: 10.1097/PEP.0000000000000242
  • Free


Ankle-foot orthoses (AFO) are an essential rehabilitation strategy employed to enhance the walking limitations seen in children with cerebral palsy (CP) who are ambulatory.1 A consensus conference of the International Society for Prosthetics and Orthotics identified the aims of lower extremity orthotic management in children with CP: (1) to correct and/or prevent deformity, (2) to provide a base of support, (3) to facilitate training of motor skills, and (4) to improve efficiency of walking.2

A literature review revealed some low-level evidence that AFOs enhance walking activity through a combination of biomechanical and physiological mechanisms.2 The solid AFO (SAFO) specifically limits dynamic ankle equinus and midfoot pronation allowing for foot flat contact with the surface during the stance phase of gait. This increased base of support (foot flat vs forefoot/toe contact during the stance phase of gait) improves balance and stability as the tibia and body move over the foot during midstance of each step. Preventing dynamic equinus (plantar flexion) has been shown to facilitate ground clearance of the swing foot, increase step length and walking speed, improve stability during stance phase, and pre-position the foot in terminal swing phase.2 Various AFO designs have been documented to improve stride length, walking speed, single-limb stance, dorsiflexion at heel strike, and ankle moment at push-off; reduce equinus posturing and ankle excursion during loading; and enhance ankle power at push-off in children with CP.2

Clinically, lower extremity impairments (passive range of motion, segment alignment) and gait patterns (kinematics) are examined in the process of orthotic prescription, but are not consistently identified and/or agreed upon in the literature. The goal of each AFO prescribed for a child with CP is the collective improvement of these biomechanical variables to increase the ease of taking an individual step, with the potential to enhance walking activity and functional skills. For example, Buckon and colleagues3 documented normalized ankle kinematics, improved stride length and walk/run/jump skills with either the posterior leaf spring or hinged AFO as compared with a rigid or SAFO in children with CP who are ambulatory.

Physiologically, we know that children with CP expend more energy to walk than children who are typically developing (TD), and that energy cost increases as functional level decreases.4 Recently, lower physical activity levels were also found to be associated with higher oxygen cost of walking in 10 children with CP who were ambulatory.5 However, Maltais et al6 reported lower oxygen cost for walking in children with spastic CP while wearing a hinged AFO with no effect on standing and walking/running/jumping skills. Thus, AFO use might affect walking activity levels by decreasing the oxygen cost of walking.

The use of AFOs has developmental and psychosocial implications for children with CP and their families. Children with physical disabilities are at risk for delayed social development.7,8 Facilitation of an upright posture positively supports acquisition of cognitive, visual perceptual, play, and social interaction skills, as well as walking independence. Naslund et al9 described parental perceptions of the use of dynamic ankle-foot orthoses (DAFO) using structured parental interviews. Parents noted positive functional effects of the DAFO for foot support, balance, standing, and sitting posture as well as overall physical activity. Parents also reported foot pain with new orthoses and the need to change socks often because of excessive sweating when wearing plastic orthoses.9 Finding shoes that fit over the AFO was also a problem. Some parents noted that the DAFO seemed to make younger, smaller children more clumsy, as they got in the way of floor play.9 Having to don and doff orthoses was noted as a burden of care.

Orthotic intervention has large economic implications for children with CP and their families and insurers. Given that approximately 53 000 AFOs are fabricated each year in the United States at an average Medicare reimbursement of $417, more than $2.2 million per year is spent on them.10,11 Further potential orthotic costs range from $6400 to $15 400 for casting and fabrication (depending on speed of growth) for children from 2 to 9 years old.

The literature examining the effect of orthoses on walking in children with CP has focused primarily on measures of activity “capacity” (defined by the International Classification of Functioning and Disability [ICF] as what a child can do in a laboratory/clinic environment)12 using computerized 3-dimensional gait analysis, gross motor function tests, energy cost, and clinical gait analysis. To date, activity “performance” (what a child does in the day-to-day environment according to the ICF) has not been reported.13 Hence, the aim of this pilot study was to examine the effect of AFOs on walking activity within community-based settings in children with CP.


This study was a prospective randomized cross-over design with a convenience sample of 11 participants. With prior approval from the human subjects review committee, a focused mailing was addressed to potential participants from a specialty care pediatric facility in the US Pacific northwest and local therapy providers. Children having a diagnosis code of ambulatory CP and ages 2 to less than 10 years made up the initial mailing list. This list was further screened before mailing to confirm ambulatory status and use of English as the primary language.

After obtaining informed consent and assent, as appropriate, participants were enrolled who met the additional inclusion criteria of (1) Gross Motor Function Classification System (GMFCS) levels I to III, (2) bilateral CP, (3) wearing bilateral AFOs more than 8 hours per day for more than 1 month, (4) the primary goal of current AFOs was to facilitate balance and walking, and (5) the family was willing to discontinue AFO use for 2 weeks. Exclusion criteria included having visual impairment that limited physical activity, lower extremity injection therapy in the past 3 months, medication changes planned during the study period, an uncontrolled seizure disorder that affected mobility skills, neurosurgical or orthopedic surgeries in the past 6 months, or other surgeries or procedures in the past 2 weeks.

At a center-based baseline study visit, demographics, current AFO prescription, and shoe design were documented (Table 1). Participants then underwent a sagittal plane video vector gait analysis (Contemplas Motion Analysis, Templo Version 7, zFlo Motion Analysis Systems, Inc, Boston, Massachusetts) with shoes only, and shoes with current AFOs. Footwear shoe profiles were similar between conditions but were not the same shoe because of size differences. After these assessments were completed, the subject was assigned to an initial intervention wear phase (currently prescribed AFO-ON/footwear or AFO-OFF/footwear) by opening a sealed opaque randomization envelope. After the child was assigned to an intervention wear phase, the StepWatch (SW) multiaxis accelerometer (Orthocare Innovations, Mount Lake Terrace, Washington) was fitted to the lateral side of the left ankle in a knit cuff (either with or without the AFO per randomization) and calibrated to the child's walking pattern per manufacturer guidelines by adjusting sensitivity and cadence settings to suit individual walking patterns in each condition (AFO-ON or AFO-OFF). Calibration of the SW accelerometer is essential to accurately document differences in walking activity levels between conditions for each child. Participants were instructed to wear the SW all their waking hours for 14 days except when bathing or swimming. A home visit by the primary author was then carried out wherein the SW data were downloaded to a laptop computer. Participants then changed to the opposite intervention wear phase, and the SW recalibrated to the walking pattern of the new condition. Participants then wore the SW for 14 days and returned the monitor and cuff to study staff via postage-paid envelope.

Subject and Intervention Characteristics

Functional gross motor level was documented using the GMFCS16 (Table 1). Sagittal plane barefoot video from the baseline visit was viewed to classify type of gait pattern according to the criteria described by Rodda et al14 (eg, jump, equinus, or crouch) by observation of shoes-only gait at midstance. Video vector gait analysis was used to assess the influence of the AFO and footwear on lower extremity alignment.17 A still picture of midstance was printed from the sagittal video and bilateral shank-to-vertical angles (SVAs) manually measured (Figure 1). Interrater reliability (percentage of absolute agreement) of SVA measures between the primary author and a research assistant was 95% across 66 pictures.

Fig. 1
Fig. 1:
Shank to vertical angle at midstance phase of gait.

Community-based walking activity was examined with the SW. The SW is designed to record steps in each time interval by identifying the magnitude and timing of multiaxial accelerations that occur with each step, usually foot-off, but sometimes other gait events. Accuracy of calibration to individual walking patterns and treatment conditions was checked against visual observation of stride counts during a more than 100-stride walking trial wearing the SW. Strides were manually counted with a handheld counter and compared with the SW recording of strides. A ratio of agreement was taken and averaged. Accuracy with respect to manual counts and comparison to other pedometers confirms the accuracy and precision of the SW for detecting strides taken.18 The primary outcome of walking activity level was summarized through average total strides per day. Secondary outcomes were percent daytime hours walking and walking intensity captured by the number of strides taken at a rate greater than 30 strides/min, peak activity index (the average of the top 30 one-minute stride counts/day), and stride activity curves.19

Participants were randomized to start with or without the AFO, (AFO-ON or AFO-OFF [with footwear only], respectively) for 2 weeks, and then switch to the opposite condition for another 2 weeks. Participants wore the SW during the entire 4-week study period; therefore, each participant contributed 2 weeks of SW data to the AFO-ON condition and 2 weeks of SW data to the AFO-OFF condition. Consistent with published SW monitoring protocols for children,19–22 5 days (4-week days and 1 weekend day) from the second week of monitoring were selected for analysis of walking activity variables.22 StepWatch data were considered valid for analysis if less than 3 hours of inadequate monitoring were found (eg, monitor worn upside down) or no stride counts that were unexplained (eg, bathing) during daytime hours (6:00 am to 10:00 pm). All participants maintained their typical daily activities for the 4 weeks of monitoring (ie, school was in session).

Demographics and clinical impairments were reported descriptively. Because of the small sample size and paired nature of outcomes, between-treatment group condition (AFO-ON vs AFO-OFF) effects were examined with the nonparametric Wilcoxon signed-rank test for paired data (α set at 0.05). To capture individual effects, between-treatment condition data were plotted and examined for greater than 1 standard deviation change from the AFO-OFF condition, on the basis of the hypothesis that the current AFO prescription would positively enhance community walking.


Eleven participants (S1-S11) were enrolled and completed the protocol. Average age was 4.3 years (range 3.0-6.0 years, Table 1). These children were classified as GMFCS levels I (n = 1), II (n = 9), and III (n = 1), with gait patterns characterized as equinus (n = 5), jump (n = 3), and crouch (n = 3). Current orthoses included SAFOs (n = 4) with the ankle angle in the AFO ranging from −5° (plantar flexion) to 0° (neutral/plantigrade), nonarticulated AFOs with plantar flexion (PF) stop at neutral (ie, 90°) and free dorsiflexion (DF) (n = 3), hinged AFOs with a range of 0° PF to 15° DF (n = 3), and supramalleolar orthoses (n = 1). All participants wore tennis shoes with round soles and negative heels, except 1 who had a flat sole and point loading rocker at approximately 85% of shoe length (S11).

Two participants (S3, S11) had wedging of the sole of their shoes to optimize the SVA during static standing and midstance per their clinical orthotist/therapist prescription. On the basis of a published orthotic management algorithm, an optimized SVA during static standing and midstance of walking is when the shank is inclined to allow the knee to be over the toes and thigh vertical.15 For the AFO-OFF condition, midstance SVAs ranged from −5° (reclined) to 32° (inclined) across all limbs (Table 1). Calibration accuracy of SW stride count to manual stride count averaged 100% (range 94-108) across all treatment conditions.

No significant difference was found in the primary outcome of average daily total step count between AFO-ON and AFO-OFF (P = .48). The between-treatment condition comparison of the secondary outcomes, percentage of time walking each day, average number of strides each day more than 30 strides/min, peak activity index, and stride rate curves showed no significant differences (P = .33-0.79, Table 2 and Figure 2).

Fig. 2
Fig. 2:
Walking stride rate curves for AFO-ON and AFO-OFF conditions (n = 11). These curves are the mean group trajectory of minutes spent at increased stride rates (solid and open circles) and 95% confidence interval (vertical lines).
Average (1 SD) of StepWatch Variables by Intervention Condition

Within subject comparison using the criterion of greater than 1 standard deviation change from AFO-OFF condition identified 2 children (18%) who took a greater number of steps/day with AFO-OFF (S4 and S10) and 2 (18%) who did better with AFO-ON (S3 and S11, Figure 3A). For percent time walking each day, 4 (36%) participants walked more each day with AFO-ON (S1, S3, S8, and S11) and 1 (9%) walked more with AFO-OFF (S10, Figure 3B). Numbers of strides/day more than 30 strides/min and peak activity index were greater during the AFO-ON condition for 2 participants (S3 and S11) and less for 1 (S2, Figure 3C/D). Only 2 subjects (S3 and S11) increased both walking activity level (number steps/day, percent time walking) and intensity (number of strides/day >30 strides/min, peak activity index) with AFO-ON.

Fig. 3
Fig. 3:
StepWatch walking activity data comparing AFO-ON and AFO-OFF. (A) Average daily total steps count. (B) Percentage of active time walking. (C) Average number of strides more than 30 strides/min. (D) Peak activity index. Red arrows indicate greater than 1 standard deviation improvement with AFO-ON. Yellow arrows indicate greater than 1 standard deviation improvement with AFO-OFF. Red circled data indicate participants with shank to vertical angle addressed in prescription. One standard deviation of change is based on the group AFO-OFF condition.


We did not find consistently favorable community-based walking activity outcomes for the AFO-ON condition compared with the AFO-OFF condition. The within-subject analysis showed large variability in outcomes between the 2 conditions. This variability may be a function of a general lack of consistency in orthotic prescription on the basis of gait pattern and biomechanical impairments. This includes multiple orthoses employed for the same gait pattern, heterogeneity of the study sample, and/or the general population of children with CP that are ambulatory, and the lack of individualization of shoes and SVAs. The results of this pilot study suggest that the majority of participants were not currently wearing orthoses and/or footwear prescriptions that positively influenced their daily walking activity levels or the secondary outcomes of walking intensity. The 2 subjects for whom the SVA was explicitly optimized (1 with a shoe modified to have a point loading rocker) demonstrated a positive effect of AFO/footwear use on daily walking levels. This positive effect was also documented for the secondary outcomes of walking time and walking intensity for these 2 subjects.

AFO management in CP must positively influence day-to-day walking activity. As compared with children who are TD, youth with CP take significantly fewer strides each day and spend less time walking.21 Relative to intensity or patterns of walking, youth that are TD spend a similar number of strides and/or time at low (1-30 strides/min) and moderate rates (30-60 strides/min), whereas the day-to-day walking of youth with CP is predominately at low rates.21 Recent work has documented a positive association between daily walking levels and intensity with mobility-based participation in daily life for youth with CP.21,23 Also, from a public health perspective, youth with CP regardless of GMFCS level demonstrate maximal walking activity levels that are far below those recommended for overall health (60 min/day of moderately vigorous activity).21,24

The orthoses worn by the children in this study were not in accord with previously published algorithms matching orthoses to gait pattern.14 Our data suggest that several subjects were currently wearing prescriptions that did not address the segmental biomechanical limitations of their presenting gait pattern (S2, S6, S9, and S10). For example, subjects 2 and 10 with crouch gait patterns were wearing hinged AFOs that would be unable to limit excessive tibial progression during stance. A child with a crouch gait pattern, per published algorithms, should be prescribed a device that limits shank inclination during midstance (eg, a SAFO). Assuming that the remaining subjects (S1, S3, S4, S5, S7, S8, and S11) were wearing orthoses that had potential to address their individual gait impairments, only 2 participants (S3 and S11) had a greater than 1 standard deviation change in walking activity levels and intensity during the AFO-ON versus the AFO-OFF condition.

Numerous authors have proposed theoretical guidelines for the optimal SVA for standing and walking in SAFOs.25–27 These proposed recommendations range from “slight incline” and “knee cap over metatarsophalangeal joints” to specific ranges (eg, 7°-10° incline). In 1972, Glancy and Lindseth,28 on the basis of visual gait analysis, proposed 3° to 5° of incline. In 1992, Hullin et al29 proposed 0° with a rocker sole and 10° incline without a rocker sole. Owen reported SVA tuned to optimum alignment using a video vector analysis of approximately 7° to 15° (mean 11.4°).30 Most recently, Jagadamma et al31,32 proposed an average SVA of 10.8° incline on the basis of gait analysis in youth with CP. The individual SVA data for the 4 subjects in this study wearing SAFOs (S3, S7, S8, and S11) were broader than the values reported in the literature, which may have contributed to our observation of an inconsistent positive group effect on walking activity.

These results support the need for further research on the effect of AFO/footwear prescription relative to the gait pattern and physical and neuromotor impairments of each limb for each client. This concurs with emerging recommendations that the SVA needs to be individualized for each leg within each patient depending on their gait pattern and diagnosis.33 Orthotic management also needs to account for footwear as an influencing factor in the functional outcomes of an individualized prescription. If future work confirms the influence of footwear on walking outcomes, fiscal and policy implications will follow because footwear is not traditionally reimbursed in some countries (eg, the United States).

Study limitations should guide the interpretation of these pilot data. First, the sample size was small and maybe under powered to find true differences between treatment conditions. Although the randomized cross-over design does somewhat mitigate this issue, a larger sample size is needed to corroborate these findings. Clinical heterogeneity of this study sample and the broader population of children with CP who are ambulatory could confound the effect of AFO use on walking activity outcomes. More work is needed to understand the influence of the SVA and shoe modifications within orthotic management. Such studies would be enhanced by use of full kinetic and kinematic analyses in addition to step activity monitoring. A key strength of this project was that the type of monitoring used, which can be feasibly implemented in clinical practice, allowed walking activity to inform orthotic management. In contrast to much of the literature, this study describes specific components of each individual's AFO/footwear, facilitating interpretation and/or clinical translation of the results.

Monitoring of walking activity performance during orthotic management has the potential to document the functional effect of orthoses within the context of day-to-day life in children with CP who are ambulatory. Measurement of the SVA from still frames of sagittal plane video has potential as a relatively low tech clinical outcome to document the influence of orthotic prescription on shank alignment during midstance. These methods can be incorporated within the orthotic fitting process to ensure the correct prescription and/or shoe modifications on the basis of observation of stance phase slow motion or freeze frame video. Shoe modifications and optimization of SVA during all phases of gait warrant further research to understand the biomechanical mechanisms of action and clinical indications.


This pilot study documented inconsistent influence of clinically prescribed AFO/footwear use on the primary outcome of day-to-day stride levels in a cohort of children with bilateral CP presenting with the 3 common gait patterns observed in this population. Varying results were observed for secondary outcomes of time spent walking each day and walking intensity. Contrary to our clinical intuition, the within-subject analysis of this study sample suggests that use of clinically prescribed AFO/footwear may be negatively associated with daily stride activity. However, the 2 participants for whom SVA was explicitly optimized (1 with a shoe modified to include a point loading rocker) documented positive changes in both daily walking levels and intensity. Future work is warranted to document the outcomes of clinical orthotic management in children with CP. This work should focus on defining the essential clinical factors of individualized orthotic prescription to optimize daily walking activity and function.


1. Gage JR. The Treatment of Gait Problems in Cerebral Palsy. London: Mac Keith Press; 2004.
2. Morris C, Condie D. Recent Developments in Healthcare for Cerebral Palsy: Implications and Opportunities for Orthotics: Report of a Meeting held at Wolfson College. Oxford; 2008-2009:8–11.
3. Buckon CE, Thomas SS, Jakobson-Huston S, Moor M, Sussman M, Aiona M. Comparison of three ankle-foot orthosis configurations for children with spastic diplegia. Dev Med Child Neurol. 2004;46(9):590–598.
4. Johnston TE, Moore SE, Quinn LT, Smith BT. Energy cost of walking in children with cerebral palsy: Relation to the Gross Motor Function Classification System. Dev Med Child Neurol. 2004;46(1):34–38.
5. Maltais DB, Pierrynowski MR, Galea VA, Bar-Or O. Physical activity level is associated with O2 cost of walking in cerebral palsy. Med Sci Sports Exerc. 2005;37(3):347–353.
6. Maltais DB, Bar-Or O, Galea VA, Pierrynowski MR. Use of orthoses lowers the O2 cost of walking in children with spastic cerebral palsy. Med Sci. 2001;33(2):320–325.
7. Tamm M, Skar L. How I play: roles and relations in the play situations of children with restricted mobility. Scand J Occup Ther. 2000;7:174–182.
8. Missiuna C, Pollock N. Play deprivation in children with physical disabilities: the role of occupational therapist in preventing secondary disability. Am J Occup Ther. 1991;45:882–888.
9. Naslund A, Tamm M, Ericsson AK, von Wendt L. Dynamic ankle-foot orthoses as a part of treatment in children with spastic diplegia-parents' perceptions. Physiother Res Int. 2003;8(2):59–68.
10. Davids JR, Rowan F, Davis RB. Indication for orthoses to improve gait in children with cerebral palsy. J Am Acad Orthop Surg. 2007;15:178–188.
11. Parker K, Naumann S, Cleghorn WL. Analysis of a paediatric ankle-foot orthosis. J Rehabil Res. 1994;264:30–31.
12. World Health Organization. International Classification of Functioning, Disability and Health (ICF). Geneva: World Health Organization; 2002.
13. Morris C, Dias LS. Cerebral palsy. Paeditric Orthotics. London: Mac Keith Press; 2007:85–100.
14. Rodda J, Graham HK. Classification of gait patterns in spastic hemiplegia and spastic diplegia: a basis for a management algorithm. Eur J Neurol. 2001;8:98–108.
15. Owen E. A clinical algorithm for the design and tuning of ankle-foot orthosis footwear combinations (AFOFCs) based on shank kinematics. Gait Posture. 2005;22S:36–37.
16. Palisano R, Rosenbaum P, Bartlett D, Livingston MH. GMFCS-R & E Gross Motor Function Classification System Expanded and Revised, 2007: CanChild Centre for Childhood Disability. McMasters University, Hamilton, ON; 2007.
17. Owen E. The importance of being earnest about shank and thigh kinematics especially when using ankle-foot orthoses. Prosthet Orthot Int. 2010;34(3):254–269.
18. Bjornson KF, Yung D, Jacques K, Burr R, Christakis D. Accuracy and precision of the StepWatch in stride counting and oxygen consumption. J Pediatr Rehabil Med. 2012;5:7–14.
19. Bjornson KF, Song K, Zhou C, Coleman K, Myaing M, Robinson SL. Walking stride rate patterns in children and youth. Pediatr Phys Ther. 2011;23(4):354–363.
20. Bjornson K, Song K, Lisle J, et al. Measurement of walking activity throughout childhood: influence of leg length. Pediatr Exerc Sci. 2010;22(4):581–595.
21. Bjornson K, Zhou C, Stevenson RD, Christakis D, Song K. Walking activity patterns in youth with cerebral palsy and youth developing typically. Disabil Rehabil. 2014;36(15):1279–1284.
22. Ishikawa S, Kang M, Bjornson KF, Song K. Reliably measuring ambulatory activity levels of children and adolescents with cerebral palsy. Arch Phys Med Rehabil. 2013;94(1):132–137.
23. Bjornson K, Zhou C, Stevenson RD, Christakis D. Relationship of stride activity to participation in mobility-based life habits among children with cerebral palsy. Arch Phys Med Rehabil. 2014;95(2):360–368.
24. US Dept of Health and Human Services. Physical Activity Guidelines for Americans: Fact Sheet for Professionals. Accessed February 6, 2015.
25. Jebsen RH, Corcoran PJ, Simons BC. Clinical experience with a plastic short leg brace. Arch Phys Med Rehabil. 1970;51:114–119.
26. Fulford GE, Cairns TP. The problems associated with flail feet in children and their treatment with orthoses. J Bone Joint Surg. 1978;60-B:93–95.
27. Nuzzo RM. A simple treatment of genu recurvatum in ataxic and athetoid cerebral palsy. Orthopedics. 1986;9(9):1223–1227.
28. Glancy J, Lindseth RE. The polypropylene solid ankle orthosis. Orthot Prosthet. 1972;26(1):14–26.
29. Hullin MG, Robb JE, Loudon IR. Ankle-foot orthosis function in low-level myelomeningocele. J Pediatr Orthop. 1992;12(4):518–521.
30. Owen E. Shank angle to floor measures of tuned “ankle-foot orthosis footwear combinations” used with children with cerebral palsy, spina bifida and other conditions. Gait Posture. 2002;16(Suppl. 1):S132–133.
31. Jagadamma KC, Coutts FJ, Mercer TH, et al. Effects of tuning of ankle foot orthoses-footwear combination using wedges on stance phase knee hyperextension in children with cerebral palsy—preliminary results. Disabil Rehabil Assist Technol. 2009;4(6):406–413.
32. Jagadamma KC, Owen E, Coutts FJ, et al. The effects of tuning an ankle-foot orthosis footwear combination on kinematics and kinetics of the knee joint of an adult with hemiplegia. Prosthet Orthot Int. 2010;34(3):270–276.
33. Owen E. From stable standing to rock and roll walking (Part 1). The importance of alignment, proportion and profiles. Assoc Chartered Paediatr Physiotherapist. 2014;5(1):7–18.

ambulation; ankle-foot orthoses; cerebral palsy; child; gait

Copyright © 2016 Academy of Pediatric Physical Therapy of the American Physical Therapy Association